Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Kankeu Fonkoua LA, Chakrabarti S, Sonbol MB, Kasi PM, Starr JS, Liu AJ, Nevala WK, Maus RL, Bois MC, Pitot HC, Chandrasekharan C, Ross HJ, Wu TT, Graham RP, Villasboas JC, Weiss M, Foster NR, Markovic SN, Dong H, Yoon HH.
Kankeu Fonkoua LA, et al. Among authors: foster nr.
Int J Cancer. 2021 Jul 15;149(2):378-386. doi: 10.1002/ijc.33559. Epub 2021 Mar 26.
Int J Cancer. 2021.
PMID: 33739449
Free PMC article.